Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00231283 · ClinicalTrials.gov registry record · Phase 3
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions
A Phase 3 study, sponsored by Cordis US.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT00231283 is a Phase 3 study that has completed, run by Cordis US. The registered enrollment target is 100 participants.
The verdict
NCT00231283, a Phase 3 study, has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the effectiveness and safety of the CYPHER NxT Sirolimus-eluting Coronary Stent on the BX SONIC Over-the-Wire (OTW) Stent Delivery System (SDS) in patients with de novo native coronary artery lesions.
Interventions
- DEVICE CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2004-04 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00231283
The ClinicalTrials.gov registry entry for NCT00231283 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS) is the first listed.
NCT00231283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00231283 about?
NCT00231283 is a clinical study titled "NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions". The objective of this study is to evaluate the effectiveness and safety of the CYPHER NxT Sirolimus-eluting Coronary Stent on the BX SONIC Over-the-Wire (OTW) Stent Delivery System (SDS) in patients with de novo native coronary artery lesions.
What is the current status of trial NCT00231283?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2004-04. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00231283?
The interventions under investigation include: CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS) (DEVICE).
Who is sponsoring clinical trial NCT00231283?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.